Bringing the fundamentals into focus…
Back to Generate Biomedicines, Inc.
How Generate Biomedicines, Inc. stacks up
GENB · against 423 other Healthcare companies of similar size
Profitability
1/ 100
Near the bottom of its peers.
Ranked #419 of 424 · scores higher than 0% of peers
Bars: peers in each 10-point band of the profitability score31 peers with a profitability score of 0–9, including GENB · Click a bar to see the companies
Why profitability scores 1?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and operating margin, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 97% of peers. Return on invested capital: -385.8% vs peer median 4.7%
- a thinner operating margin: weaker than 94% of peers. Operating margin: -737.0% vs peer median 7.1%
- Return on assets is not reported, so it is left out of the score.
Metric by metric
Position: dot = GENB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | GENB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 400 reported | -385.8% | 5.8% | 2% | 33% | |
| Operating marginHigher is better · 391 reported | -737.0% | 7.6% | 4% | 33% | |
| Return on assetsHigher is better · 407 reported | Not reported | 2.0% | — | — | 33% |
| Return on equityHigher is better · 391 reported | Not reported | 4.6% | — | — | Context only |
| Gross marginHigher is better · 438 reported | 0.0% | 47.3% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around GENB| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 411 | 2.3B USD | 3 | 26 | |
| 411 | 2.0B USD | 3 | 24 | |
| 417 | 1.7B USD | 2 | 30 | |
| 417 | 1.8B USD | 2 | 23 | |
| 419 | 1.8B USD | 1 | 30 | |
| 419 | 1.0B USD | 1 | 32 | |
| 419 | 1.2B USD | 1 | 21 | |
| 419 | 1.3B USD | 1 | 44 | |
| 423 | 1.2B USD | 0 | 6 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score